Digital dilemma in UK’s life sciences job market
Pharmaceutical Technology
SEPTEMBER 8, 2023
In this issue: Digital jobs in UK life sciences, generative AI changes drug discovery, and how robotics is impacting gene therapy manufacturing.
This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Pharmaceutical Technology
SEPTEMBER 8, 2023
In this issue: Digital jobs in UK life sciences, generative AI changes drug discovery, and how robotics is impacting gene therapy manufacturing.
Pharmaceutical Technology
APRIL 20, 2023
European life sciences venture capital firm Forbion has raised €1.35bn ($1.47bn) across its two new funds. The funds were created to cater to the needs of two distinct segments of the market. The Forbion Growth Opportunities Fund II provides support to the expansion of late-stage life sciences companies.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
NOVEMBER 25, 2022
XtalPi has entered a strategic partnership with CK Life Sciences for artificial intelligence (AI)-driven tumour vaccine research and development (R&D). The aim of the alliance is to bring to market precision therapy for patients globally. In September 2020, the company raised funds worth $318.8m
Bio Pharma Dive
JUNE 15, 2022
The fund, Third Rock’s sixth, comes amid a significant downturn in the biotech stock market, which has raised questions about the viability of young drug startups.
Bio Pharma Dive
OCTOBER 17, 2022
Learn how to attract and retain top talent, in an ultra-competitive labor market.
Bio Pharma Dive
DECEMBER 11, 2023
Research from Everest Group shows how life sciences leaders are investing in process mining to speed time-to-market, improve regulatory compliance and drive innovation.
pharmaphorum
JUNE 20, 2024
Discover how AI-powered analytics are revolutionising life sciences marketing. Learn how to leverage these cutting-edge technologies to drive insights and success in the industry.
Pharma Mirror
SEPTEMBER 6, 2023
by Nataliya Andreychuk, Co-founder and CEO of Viseven Many pharma brands still shy away from marketing directly to patients, depending on conversion through healthcare providers (HCPs). And it is not hard to see why.
Pharma Mirror
MAY 19, 2021
Azbil Telstar announces the appointment of Rashedi Hassan as a Sales & Marketing Manager of the subsidiary of the company in Dhaka, Bangladesh. The post Rashedi Hassan takes over Sales & Marketing management of Telstar’s subsidiary in Bangladesh appeared first on Pharma Mirror Magazine. With more than 18.
Bio Pharma Dive
JUNE 30, 2023
The life sciences investor spoke with BioPharma Dive about emerging life sciences markets around the globe and why the firm invests in first-time biotech founders.
Cloudbyz
NOVEMBER 22, 2024
The Everest Group PEAK Matrix® is an industry-standard evaluation that ranks service providers on two essential dimensions: market impact and vision & capability. We are deeply honored to be recognized in Everest Group’s PEAK Matrix® for Life Sciences CTMS solutions,” said Dinesh Kashyap, CEO and Founder of Cloudbyz.
XTalks
MARCH 19, 2025
This week, were celebrating a significant milestone: the release of our 200th episode of the Xtalks Life Science Podcast ! We’re excited to continue our journey by bringing you more in-depth conversations with industry leaders, highlighting the innovations and trends that shape the future of life sciences.
Pharmaceutical Technology
JULY 28, 2022
In the life sciences sector, one country is significantly outstripping others for FDI. Data shows that almost 40% of all life sciences subsidiaries are located in the US. After all, around a third of the world’s leading life sciences corporations have their headquarters in the country.
XTalks
JUNE 9, 2023
Consistency is a key factor in any successful life science content marketing strategy. By keeping the conversation going, content marketers within the life science industry can build trust with their audience and create a loyal following that will continue to engage with their content and products over time.
Intouch Solutions
OCTOBER 20, 2023
This year’s Dreamforce conference – the annual gathering for Salesforce, one of the main providers in commercial marketing and sales technology for the Health & Life Science (HLS) industry – was bigger and more innovative than ever. But what news will matter most for health & life sciences companies?
Pharmaceutical Technology
DECEMBER 14, 2022
GSK has entered a strategic partnership with Wave Life Sciences to progress the discovery and development of oligonucleotide therapies for new genetic targets. On completion of the first-in-patient clinical trial by Wave, GSK will be in charge of the development and marketing works.
Pharmaceutical Technology
SEPTEMBER 15, 2022
From the Human Genome Project to contemporary drug development, collaboration is critical to the life sciences. It is also an important factor in the success of life sciences clusters, where a high concentration of pharmaceutical or medical device companies can all be found in one district, city or region.
Pharmaceutical Technology
JUNE 16, 2023
for an undisclosed sum, boosting its life science AI capabilities. The deal enables Verix to further improve its capacities to use AI to advance the brand growth of life science companies. Verix states that it leverages AI to provide more in-depth, precise data on the market more quickly and at a lower cost.
Intouch Solutions
JANUARY 9, 2024
But what does this mean, specifically, for marketers in the life sciences industry? In late 2023, we spoke with 30 life-sciences marketers. Artificial intelligence is reshaping how the world lives and works. How is it changing our jobs? How do we want it to?
XTalks
JUNE 26, 2023
Content marketing not only builds trust and credibility but also helps in driving brand awareness which attracts potential customers. Life science companies can position themselves as authoritative sources, create a community of loyal followers and influence purchasing decisions by leveraging content marketing strategies.
Bio Pharma Dive
AUGUST 31, 2022
Drew Panayiotou led marketing efforts at Alphabet’s life sciences arm Verily, and his appointment is Pfizer’s third senior-level hire this year.
XTalks
SEPTEMBER 12, 2023
Life science podcasts have emerged as an invaluable tool for building connections with audiences in the digital era. Furthermore, we’ll explore the unique advertising opportunities that this platform offers, positioning brands at the forefront of the life science industry. The result?
pharmaphorum
JANUARY 9, 2024
Discover how AI innovations are revolutionising the engagement between life sciences companies and healthcare professionals. Learn about the latest advancements and their impact on the industry.
BioPharma Reporter
MAY 15, 2024
Ahead of Bio 2024, we caught up with Matt Cokely, global technical consultant strategic leader, and Helen Gates, marketing director, at Ecolab Life Sciences to find out what the company is planning for the event and how it is navigating current challenges in the industry.
BioPharma Reporter
MAY 15, 2024
Ahead of Bio 2024, we caught up with Matt Cokely, global technical consultant strategic leader, and Helen Gates, marketing director, at EcoLab Life Sciences to find out what the pharmaceutical manufacturing firm is planning for the event and how it is navigating current challenges in the industry.
XTalks
DECEMBER 20, 2023
As we step into 2024, the life sciences continue to evolve at an unprecedented pace, driven by technological innovation, a deeper understanding of human biology and the application of new technologies in areas like drug development and health wearables. The global wearable medical devices market size was valued at $73.77
Outsourcing Pharma
MAY 9, 2024
A collaborative report released today (May 9) by Medicines Discovery Catapult (MDC), sheds light on the challenges facing the life sciences sector amidst recent economic turbulence.
Cloudbyz
SEPTEMBER 10, 2023
The challenge of managing and securing sensitive data, including PHI and PII, is significant for life sciences organizations. Additionally, the consequences of data breaches can be severe for life sciences organizations. The challenge is further compounded by the need for fast and accurate analysis of data.
Intouch Solutions
NOVEMBER 16, 2023
The annual event assembled nearly 1,000 attendees from over 40+ countries across the healthcare ecosystem to learn, network and explore industry challenges, strategic trends and solutions in life sciences and healthcare.
Drug Channels
MARCH 28, 2024
Today’s guest post comes from Bill Dupere, SVP of Product Development & Partnerships at Mercalis. Bill discusses specialty therapy access barriers, including payer utilization management techniques and “no coverage” policies. Contact Mercalis to learn about their Patient Support Services. Read on for Bill’s insights.
Pharmaceutical Technology
JULY 14, 2023
Emmaus Life Sciences has received marketing authorisation for Endari (L-glutamine oral powder) in Oman for sickle cell disease.
BioPharma Reporter
NOVEMBER 16, 2023
The Pistoia Alliance is a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D. It has just announced its four new strategic priorities made up of global pharma and tech representatives to deliver new project ideas to drive industry change.
Cloudbyz
MARCH 17, 2024
In the dynamic world of life sciences, where innovation is paramount, the integration of cutting-edge technologies is crucial for accelerating clinical operations and driving breakthroughs in healthcare. Salesforce’s recent announcement of its Life Sciences Cloud marks a significant stride towards this goal.
pharmaphorum
JANUARY 6, 2023
From enabling patient choice during clinical trials to strengthening vital partnerships across the quality ecosystem, connected data will become the lifeblood that enables life sciences teams to collaborate efficiently and effectively in 2023. He is responsible for customer engagement, market adoption, and strategic alliances.
Pharmaceutical Technology
JULY 8, 2022
These workspaces mimic their physical counterparts in all ways but are superior in several factors that are leading to explosive growth in this market. This provides invaluable usability feedback and, most importantly, makes sure that new features are embedded in the VDR platform and tested thoroughly before being released to the market.
XTalks
JANUARY 17, 2024
In this episode, hear about Monogram Orthopedics’ customized implants, which facilitate minimal processing and coordination time for orthopedic joint replacements, and how the company is going up against big industry names like Stryker and its market-leading Mako robot as well as Zimmer Biomet.
pharmaphorum
AUGUST 5, 2024
Learn how to effectively harmonise global content strategies with local needs in the pharmaceutical market. Understand the unique challenges in the life science industry and how to measure success with relevant KPIs.
pharmaphorum
OCTOBER 17, 2023
In this latest instalment of the pharmaphorum podcast, web editor Nicole Raleigh speaks with life sciences advisor Randall Hein, CEO of Heinsight LLC, and health sciences marketing expert Krystle Buntemeyer, CEO of SCORR Marketing, about the trends and changes for health sciences marketing over the past few years.
XTalks
DECEMBER 19, 2024
Roches Alecensa is the current ALK inhibitor market leader. The intracranial response rate, as confirmed by a blinded independent review committee, was 63.6 percent (seven out of 11) for patients treated with ensartinib compared to 21.1 Results from the drugs first-line eXalt3 study were published in JAMA Oncology over three years ago.
XTalks
FEBRUARY 21, 2024
These NanoAbs are being tailored to treat conditions with significant unmet medical requirements and promising market prospects, including psoriasis and asthma. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.
XTalks
JULY 5, 2023
On April 14, 2023, CytoMed’s shares began trading on the Nasdaq Capital Market under the ticker symbol “GDTC” In this episode, Mr. Choo and Dr. Tan share insights about how CytoMed Therapeutics is aiming to engineer more affordable cellular cancer therapies.
XTalks
SEPTEMBER 13, 2023
This episode features an interview with Ram Mukunda and Claudia Grimaldi from IGC Pharma , a clinical-stage pharmaceutical company focused on improving the health and well-being of patients affected by Alzheimer’s disease and bringing therapies for it to market. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.
World of DTC Marketing
JANUARY 24, 2022
The amount of money required to gain approval of a new drug has been hotly debated, but it also costs a hell of a lot of money to launch a drug in today’s market. A study in 2020 estimated that the median cost of getting a new drug into the market was $985 million, and the average price was $1.3 Only about $2.2
Pharmaceutical Technology
MAY 2, 2023
ODAIA, a life sciences predictive analytics and commercial insights provider, has secured an investment of $25m in its Series B funding round. This software-as-a-service (SaaS) platform is also used by life science brands to launch their drugs, therapeutics and vaccines in the markets, using data-driven solution.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content